Abstract
An increasing incidence of oral squamous cell carcinoma (OSCC) in individuals younger than 45 years has been observed in recent years. OSCC in younger patients differs in terms of biological behavior and prognosis with the disease being more aggressive than in older patients. The aim of this study was to analyze the immunohistochemical expression of galectins-3 and -7 in 32 cases of OSCC in young patients and to correlate this expression with clinical and morphological parameters. All cases of OSCC of the sample were diagnosed at oncology referral hospitals in Paraíba, Brazil, between 2002 and 2012. Clinical data were obtained from the patient records. Histological malignancy grading systems proposed by Bryne et al. (J Pathol 166:375–381, 1992) and the World Health Organization (In: Pathology and genetics of head and neck tumours: Word Health Organization classification of tumours, 2005) were used for morphological analysis. Immunohistochemistry was performed by the streptavidin–biotin technique using anti-galectin-3 and -7 antibodies. The results were analyzed statistically by the Chi-squared and Fisher exact tests (p < 0.05). Immunoexpression of galectin-3 was observed in 65.6 % of the cases analyzed, but showed no significant association with any of the variables studied (clinical staging; histological malignancy grading systems). Immunoexpression of galectin-7 was observed in 96.9 % of cases and was significantly associated with histological malignancy grading systems (p < 0.05). In conclusion, the results suggest the use of galectin-7 as marker of biological behavior and tumor progression in OSCC in young patients.
Similar content being viewed by others
References
Ribeiro ACP, Silva ARS, Simonato LE, Salzedas LMP, Sundefeld MLMM, Soubhia AMP (2009) Clinical and histopathological analysis of oral squamous cell carcinoma in young people: a descriptive study in Brazilians. Br J Oral Maxillofac Surg 47:95–98. doi:10.1016/j.bjoms.2008.05.004
Benevenuto TG, Nonaka CFW, Pinto LP, Souza LB (2012) Immunohistochemical comparative analysis of cell proliferation and angiogenic index in squamous cell carcinomas of the tongue between young and older patients. Appl Immunohistochem Mol Morphol 20:291–297. doi:10.1097/PAI.0b013e31823277f6
Soudry E, Preis M, Hod R, Hamzany Y, Hadar T, Bahar G, Strenov Y, Shpitzer T (2010) Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome. Clin Otolaryngol 35:307–312. doi:10.1111/j.1749-4486.2010.02164.x
Van Monsjou HS, Van Velthuysen MLF, Van Den Brekel MWM, Jordanova ES, Melief CJM, Balm AJM (2012) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 130:1806–1812. doi:10.1002/ijc.26195
Patel SC, Carpenter WR, Tyree S, Couch ME, Weisller M, Hackman T, Hayes DN, Shores C, Chera BS (2011) Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 29:1488–1494. doi:10.1200/jco.2010.31.7883
Kaminagakura E, Vartanian GJ, Silva SDS, Santos CR, Kowalski LP (2010) Case-control study on prognostic factors in oral squamous cell carcinoma in young patients. Head Neck 32:1460–1466. doi:10.1002/hed.21618
Beena VT, Chauhan I, Heera R, Rajeev R (2011) Oral cancer in young non-habituè females: a report of four cases and review of the literature. Aust Dent J 56:322–327. doi:10.1111/j.1834-7819.2011.01344.x
Falaki F, Dalirsani Z, Pakfetrat A, Falaki A, Saghravanian N, Nosratzehi T, Pazouki M (2011) Clinical and histopathological analysis of oral Squamous cell carcinoma of young patients in Mashhad, Iran: A retrospective study and review of literatures. Med Oral Patol Oral Cir Bucal 16:473–477. doi:10.4317/medoral.16.e473
Alves PM, Godoy GP, Gomes DQ, Medeiros AMC, Souza LB, Silveira EJD, Vasconcelos MG, Queiroz LMG (2011) Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue. Pathol Res Pract 207:236–240. doi:10.1016/j.prp.2011.02.004
Carvalho MV, Pereira JS, Alves PM, Silveira EJD, Souza LB, Queiroz LMG (2013) Alterations in the immunoexpression of galectins-1, -3 and -7 between different grades of oral epithelial dysplasia. J Oral Pathol Med 42:174–179. doi:10.1111/j.1600-0714.2012.01199.x
Faria PR, Chammas R, Melo TL, Hsu DK, Liu FT, Nonogaki S, Cardoso SV, Loyola AM (2011) Absence of galectin-3 does not affect the development of experimental tongue carcinomas in mice. Exp Mol Pathol 90:189–193. doi:10.1016/j.yexmp.2010.12.007
Kosacka M, Piesiak P, Kowal A, Gołecki M, Jankowska R (2011) Galectin-3 and cyclin D1 expression in non-small cell lung câncer. J Exp Clin Cancer Res 30:2–7. doi:10.1186/1756-9966-30-101
Saussez S, Lorfevre F, Lequeux T, Laurent G, Chantrain G, Vertongen F, Toubeau G, Decastercker C, Kiss R (2008) The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to the therapy. Oral Oncol 44:86–93. doi:10.1016/j.oraloncology.2006.12.014
Bryne MS, Koppang HS, Lilleng R, Kjaerheim A (1992) Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166:375–381
Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours: Word Health Organization classification of tumours. IARC Press, Lyon (France), pp 122–125
Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH, Chen YC, Chen YL, Jin YT (2008) Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early stage oral squamous cell carcinoma. Oral Oncol 44:325–334. doi:10.1016/j.oraloncology.2007.03.004
Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K, Tomiyama Y, Raz A, Kubo T (2000) Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6:4635–4640
Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK (2008) Expression of galectin-3 and galectin-7 in thyroid malignancy as potential diagnostic indicators. Singapore Med J 49:333–338
Mallet Y, Avalos N, Ridant AL, Gangloff P, Moriniere S, Rame JP, Poissonnet G, Makeieff M, Cosmidis A, Babin E, Barry B, Fournier C (2009) Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less. Acta Otolaryngol 129:1503–1508. doi:10.3109/00016480902798343
Alsharif MJ, Jiang WA, He S, Zhao Y, Shan Z, Chen X (2009) Gingival squamous cell carcinoma in young patients: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:696–700. doi:10.1016/j.tripleo.2008.12.048
Santos-Silva AR, Ribeiro ACP, Soubhia AMP, Miyahara GI, Carlos R, Speight PM, Hunter KD, Torres-Rendon A, Vargas PA, Lopes MA (2011) High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study. Histopathology 58:1127–1135. doi:10.1111/j.1365-2559.2011.03863.x
O’regan EM, Toner ME, Finn SP, Fan CY, Ring M, Hagmar B, Timon C, Smyth P, Cahill S, Flavin R, Sheils OM, O’Leary JJ (2008) p16INK4A genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 39:452–458. doi:10.1016/j.humpath.2007.08.004
Vered M, Dayan D, Dobriyan A, Yahalom R, Shalmon B, Barshack I, Bedrin L, Talmi YP, Taicher S (2010) Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol 136:1039–1048. doi:10.1007/s00432-009-0749-3
Dumic J, Dabelic S, Flögel M (2006) Galectin-3: an open-ended story. Biochim Biophys Acta 1760:616–635. doi:10.1016/j.bbagen.2005.12.020
Kapucuoglu N, Basakb PY, Bircana S, Serta S, Akkayab VB (2009) Immunohistochemical galectin-3 expression in non-melanoma skin cancers. Pathol Res Pract 205:97–103. doi:10.1016/j.prp.2008.09.001
Delorge S, Saussez S, Pelc P, Devroede B, Marchant H, Burchert M, Danguy A, Salmon I, Gabius HJ, Kiss R, Hassid S (2000) Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 122:834–841. doi:10.1016/S0194-5998(00)70010-6
Wang LP, Chen SW, Zhuang SM, Li H, Song M (2013) Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway. Pathol Oncol Res 19:461–474. doi:10.1007/s12253-013-9603-7
Zhu XI, Ding M, Yu M, Feng M, Tan L, Zhao F (2010) Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis. BMC Cancer 10:2–12. doi:10.1186/1471-2407-10-290
Demers M, Magnaldo T, St-Pierre Y (2005) Novel function for galectin-7: promoting tumorigenesis by up regulating MMP-9 gene expression. Cancer Res 65:5205–5210. doi:10.1158/0008-5472.CAN-05-0134
Matsukawa S, Morita KI, Negishi A, Harada H, Nakajima Y, Shimamoto H, Hirofumi T, Tanaka K, Oho M, Yamada T, Omura K (2014) Galectin-7 as a potential predictive marker of radio-therapy resistance in oral squamous cell carcinoma. Cancer Med 3:349–361. doi:10.1002/cam4.195
Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, hsu DK, Liu FT (2002) Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome C release. JBC 277:3487–3497. doi:10.1074/jbc.M109360200
Acknowledgments
The authors thank the National Council for Scientific and Technological Development-CNPq for financial support (n.485788/2013-6).
Conflict of interest
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mesquita, J.A., Queiroz, L.M.G., Silveira, É.J.D. et al. Association of immunoexpression of the galectins-3 and -7 with histopathological and clinical parameters in oral squamous cell carcinoma in young patients. Eur Arch Otorhinolaryngol 273, 237–243 (2016). https://doi.org/10.1007/s00405-014-3439-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3439-y